Kowal Investment Group’s Natus Medical Inc NTUS Stock Holding History

Kowal Investment Group’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	–	–	1026
2021 Q3	$0	Buy	+1	New	+$25	﹤0.01%	1039

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kowal Investment Group's NTUS Position: Q4 2021 in Review

Kowal Investment Group sold out of Natus Medical Inc (NTUS) in Q4 2021, closing a stake of 1 share.

Kowal Investment Group first reported a position in NTUS in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 172 funds tracked by Wall St. Rank hold NTUS as of Q4 2021.

Kowal Investment Group reported no remaining Natus Medical Inc position as of Q4 2021 after selling out during the quarter.
Kowal Investment Group sold 1 Natus Medical Inc share in Q4 2021.
Kowal Investment Group first reported a position in Natus Medical Inc in Q3 2021 and held it in 1 quarter.
Kowal Investment Group's Natus Medical Inc position peaked at $0 in Q3 2021.
172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.